Back
Rayliant Quantitative Developed Market Equity ETF Vs. Aligos Therapeutics Industry Stock Comparison
Buy
60
RAYD
Rayliant Quantitative Developed Market Equity ETF
Last Price:
$35.85
Seasonality Move:
-0.65%
Buy
63
ALGS
Aligos Therapeutics
Last Price:
$8.59
Seasonality Move:
-21.57%
Buy
60
Rayliant Quantitative Developed Market Equity ETF (RAYD)
is a Buy
Is Rayliant Quantitative Developed Market Equity ETF a Buy, Sell or Hold?
-
The current Rayliant Quantitative Developed Market Equity ETF [RAYD] share price is $35.93. The Score for RAYD is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
RAYD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $8.69. The Score for ALGS is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RAYD Stock Price Chart
What is Rayliant Quantitative Developed Market Equity ETF's stock price today?
-
The Rayliant Quantitative Developed Market Equity ETF share price today is $35.93Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAYD is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $8.69Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
RAYD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.87 | Buy |
Relative Strength Index (14 RSI): | 61.48 | Buy |
Chaikin Money Flow: | 2311 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.04 - 35.84) | Buy |
Bollinger Bands (100): | (31.96 - 35.18) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.47 | Buy |
Relative Strength Index (14 RSI): | 60.92 | Buy |
Chaikin Money Flow: | 37075 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.25 - 8.29) | Buy |
Bollinger Bands (100): | (4.39 - 12.23) | Buy |
RAYD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.86 | Buy |
20-day SMA: | 35.5 | Buy |
50-day SMA: | 34.8 | Buy |
200-day SMA: | 32.86 | Buy |
8-day EMA: | 25.7 | Buy |
20-day EMA: | 14.14 | Buy |
50-day EMA: | 6.51 | Buy |
200-day EMA: | 1.75 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.17 | Buy |
20-day SMA: | 7.83 | Buy |
50-day SMA: | 6.65 | Buy |
200-day SMA: | 15.18 | Sell |
8-day EMA: | 8.27 | Buy |
20-day EMA: | 7.79 | Buy |
50-day EMA: | 7.66 | Buy |
200-day EMA: | 12.85 | Sell |
Rayliant Quantitative Developed Market Equity ETF Earnings Growth & RAYD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.36 per share, a decrease next quarter of $0.07 per share, an increase this year of $3.67 per share, and a decrease next year of $1.69 per share.
Rayliant Quantitative Developed Market Equity ETF Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |